-
13823-500
AX 048-500 g
Price: $366.55List Price: $407.27A potent group IVA cPLA2 inhibitor (XI(50) = 0.022) reduces thermal hyperalgesia evoked by carrageenan injection of rat hind paw (ED<sub>50</sub> = 1.2 mg/kg) does not inhibit COX activity or interfere with CB1 receptor signaling. -
-
TNR CDOA262
Drug Cup, 6 pnl, -Adlt BluRapids , AMP/BZO/COC/MET/OPI/THC; CLIA waived (C003B-023876)
Price: $187.38List Price: $208.20BluRapids®:  Part Number: CDOA261 6-Panel Multi-Drug Test Cup Tests for: Amphetamine (AMP), Benzodiazepines (BZO), Cocaine (COC), Methamphetamine (mAMP), Opiates (OPI), Cannabinoids (THC) CLIA Waived No Adulterants Features / Benefits Integr -
TNR CDOA261
Drug Cup, 6 pnl, -Adlt BluRapids , AMP/BZO/COC/MET/OPI/THC; CLIA waived (C003B-023877)
Price: $187.38List Price: $208.20BluRapids®:  Part Number: CDOA261 6-Panel Multi-Drug Test Cup Tests for: Amphetamine (AMP), Benzodiazepines (BZO), Cocaine (COC), Methamphetamine (mAMP), Opiates (OPI), Cannabinoids (THC) CLIA Waived No Adulterants Features / Benefits Integr -
M646914-10mg
MAT2A-IN-9 (C007B-374193)
Price: $1,156.50List Price: $1,285.00MAT2A-IN-9 (compound 167), a 2-oxoquinazoline derivative, is a potent MAT2A (methionine adenosyltransferase 2A) inhibitorForm:SolidIC50&: Target:MAT2A. -
M646914-5mg
MAT2A-IN-9 (C007B-374194)
Price: $718.66List Price: $798.51MAT2A-IN-9 (compound 167), a 2-oxoquinazoline derivative, is a potent MAT2A (methionine adenosyltransferase 2A) inhibitorForm:SolidIC50&: Target:MAT2A. -
N595583-100mg
N-azidoacetylmannosamine-tretraacylated (Ac4ManNAz) (C007B-376471)
Price: $2,088.58List Price: $2,320.65N-azidoacetylmannosamine-tretraacylated (Ac4ManNAz) can be used as a labelling reagent. The azide group allows for it to be reacted with alkynes.